NVS shares declined on 4/9/19 by the implied value of the ALC spin-off (0.2 shares of ALC for each share of NVS) because that was the day the ALC spin-off went ex-dividend.
I don't understand what you're referring to by the "150% orbit."
I'm not sure how well Mayzent (the new MS drug) will sell.